2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Details for Australian Patent Application No. 2010310100 (hide)

Owner UCB Pharma, S.A.

Inventors Quesnel, Yannick; Turet, Laurent; Mercier, Joel

Agent Watermark

Pub. Number AU-A-2010310100

PCT Pub. Number WO2011/047860

Priority 09173912.8 23.10.09 EP

Filing date 21 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/433 (2006.01) - Thiadiazoles

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/047860 Priority application(s): WO2011/047860

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310107-Portion capsule and method for producing a portion capsule

2010310099-A method for assessing a patient's fluid status and/or sensitivity to fluid removal, controller, and devices